Showing results (11-20 of 216) with videos related to
Sort By:
Pageof 22
Journal of Crohn'S & Colitis|April 17, 2018
Accelerated Clearance of Infliximab is Associated With Treatment Failure in Patients With Corticosteroid-Refractory Acute Ulcerative ColitisDavid Kevans, Sanjay Murthy, Diane R Mould, et al.Journal of Crohn'S & Colitis|January 3, 2018
The Unfinished Symphony: Golimumab Therapy for Anti-Tumour Necrosis Factor Refractory Crohn's DiseaseTomer Greener, Karen Boland, A Hillary Steinhart, et al.Journal of Crohn'S & Colitis|June 28, 2015
Higher Rates of Dose Optimisation for Infliximab Responders in Ulcerative Colitis than in Crohn's diseaseSarah O'Donnell, Joanne M Stempak, A Hillary Steinhart, et al.Inflammatory Bowel Diseases|March 15, 2008
Population-based case-control study of alpha 1-antitrypsin and SLC11A1 in Crohn's disease and ulcerative colitisRoman Kotlowski, Charles N Bernstein, Mark S Silverberg, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 26, 2006
Association of trough serum infliximab to clinical outcome after scheduled maintenance treatment for Crohn's diseaseElana A Maser, Renata Villela, Mark S Silverberg, et al.Inflammatory Bowel Diseases|February 21, 2002
Risk factors for low bone density in Crohn's diseaseAida Habtezion, Mark S Silverberg, Robert Parkes, et al.Gastroenterology|January 7, 2022
Time to Revisit Disease Classification in Inflammatory Bowel Disease: Is the Current Classification of Inflammatory Bowel Disease Good Enough for Optimal Clinical Management?Bram Verstockt, Brian Bressler, Helena Martinez-Lozano, et al.Inflammatory Bowel Diseases|May 31, 2014
Downregulation of expression of xenobiotic efflux genes is associated with pelvic pouch inflammation in ulcerative colitisBoyko Kabakchiev, Andrea Tyler, Joanne M Stempak, et al.F1000Prime Reports|September 4, 2014
Microbiome analysis - from technical advances to biological relevanceMichelle I Smith, Williams Turpin, Andrea D Tyler, et al.Journal of Crohn'S & Colitis|April 3, 2012
What do changes in inflammatory bowel disease management mean for our patients?Subrata Ghosh, Geert D'Haens, Brian G Feagan, et al.Pageof 22